HDI Receives $822,000 in Proceeds From Exercise of Warrants

Hypertension Diagnostics announced that on April 29 it completed the issuance of 2,756,609 shares of common stock and 173,335 shares of Series A Convertible preferred stock to holders of warrants to purchase common stock and preferred stock, resulting in gross proceeds of $822,227, which represents 91 percent of the total warrant proceeds available for exercise.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqNwLWbWbmtiYCdKYmZm)